Insider Trading - Chemomab Therapeutics Ltd. (CMMB)

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
    "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
    - Peter Lynch
    What is insider trading>>
    Time period:
    Insider Trading Transactions for Chemomab Therapeutics Ltd.
    Stock options: Exercise, Award, Grant, Conversion
    Transaction
    Date
    Reported
    DateTime
    Exercisable
    Expiration
    Company Symnbol Insider
    Relationship
    Shares
    Traded
    Conversion
    Price
    Shares
    Owned
    Filing
    2020-04-23
    Option Award
    2021-03-11
    6:33 pm
    N/A
    2030-07-15
    Anchiano Therapeutics Ltd. ANCN Cohen Neil Harris
    CEO
    55,000 $0 55,000
    (Direct)
    View
    2020-04-23
    Option Award
    2021-03-12
    4:28 pm
    N/A
    2030-07-15
    Anchiano Therapeutics Ltd. ANCN Polovets Stanislav
    Director
    55,000 $0 55,000
    (Direct)
    View
    2021-03-16
    Purchase
    2021-03-18
    9:42 pm
    N/A
    N/A
    Chemomab Therapeutics Ltd. CMMB THIEL PETER
    10% Owner
    230,536 $0 1,108,509
    (Indirect)
    View
    2021-03-16
    Purchase
    2021-03-18
    9:42 pm
    2021-03-17
    2026-03-17
    Chemomab Therapeutics Ltd. CMMB THIEL PETER
    10% Owner
    23,054 $0 23,054
    (Indirect)
    View
    2021-03-16
    Option Award
    2021-03-18
    9:59 pm
    N/A
    N/A
    Chemomab Therapeutics Ltd. CMMB OrbiMed Israel GP Ltd.
    OrbiMed Israel BioFund GP Limited Partnership
    10% Owner
    288,170 $17.35 2,578,174
    (Indirect)
    View
    2021-03-16
    Option Award
    2021-03-18
    9:59 pm
    N/A
    2026-03-16
    Chemomab Therapeutics Ltd. CMMB OrbiMed Israel GP Ltd.
    OrbiMed Israel BioFund GP Limited Partnership
    10% Owner
    28,817 $0 28,817
    (Indirect)
    View
    2021-03-16
    Purchase
    2021-03-26
    10:27 am
    N/A
    N/A
    Chemomab Therapeutics Ltd. CMMB Cohen Neil Harris
    Director
    2,409 $41.51 2,409
    (Direct)
    View
    2021-03-16
    Purchase
    2021-03-26
    10:27 am
    N/A
    2030-03-15
    Chemomab Therapeutics Ltd. CMMB Cohen Neil Harris
    Director
    688 $0 688
    (Direct)
    View
    2021-04-19
    Option Award
    2021-04-21
    5:06 pm
    N/A
    2031-04-19
    Chemomab Therapeutics Ltd. CMMB Cohen Neil Harris
    Director
    11,884 $0 11,884
    (Direct)
    View
    2021-04-19
    Option Award
    2021-04-21
    5:09 pm
    N/A
    2031-04-19
    Chemomab Therapeutics Ltd. CMMB Darvish Nissim
    Director
    11,884 $0 11,884
    (Direct)
    View
    2021-04-19
    Option Award
    2021-04-21
    5:11 pm
    N/A
    2031-04-19
    Chemomab Therapeutics Ltd. CMMB Maryles Joel Michael
    Director
    11,884 $0 11,884
    (Direct)
    View
    2021-04-19
    Option Award
    2021-04-21
    5:15 pm
    N/A
    2031-04-19
    Chemomab Therapeutics Ltd. CMMB Moses Alan Charles
    Director
    11,884 $0 11,884
    (Direct)
    View
    2021-04-19
    Option Award
    2021-04-21
    5:16 pm
    N/A
    2031-04-19
    Chemomab Therapeutics Ltd. CMMB Nicaise Claude
    Director
    11,884 $0 11,884
    (Direct)
    View
    2021-04-19
    Option Award
    2021-04-21
    5:16 pm
    N/A
    2031-04-19
    Chemomab Therapeutics Ltd. CMMB SQUINTO STEPHEN P
    Director
    23,768 $0 23,768
    (Direct)
    View
    2021-05-07
    Option Award
    2021-05-10
    4:01 pm
    N/A
    2031-05-07
    Chemomab Therapeutics Ltd. CMMB Fatal Sigal
    CFO
    35,653 $0 35,653
    (Direct)
    View